LeadIQ logo
Learn more at LeadIQ.com

Insights

Market Expansion Polpharma Biologics recently launched Tyruko, Europe's first biosimilar for multiple sclerosis. This new product can open doors to partnerships and collaborations within the multiple sclerosis treatment market.

Strategic Partnership The partnership with Formycon AG showcases Polpharma Biologics' commitment to developing biosimilars. Leveraging this partnership, the company can explore joint ventures or licensing agreements with other biopharma companies.

Legal Standout Despite legal actions from Biogen, Polpharma Biologics' resilience in the face of legal challenges highlights its competitive edge. This resilience can be a selling point to demonstrate the company's strong position in the industry.

Regulatory Progress EMA acceptance of Marketing Authorization Application for the biosimilar natalizumab signifies a step closer to market approval. This progress can be highlighted to attract potential investors or partners looking for promising biologics.

Big Pharma Collaboration Through the collaboration with Sandoz, Polpharma Biologics has strengthened its market presence. This partnership can be leveraged to explore new opportunities within the biologics market and showcase credibility to potential clients.

Similar companies to Polpharma Biologics

Polpharma Biologics Tech Stack

Polpharma Biologics uses 8 technology products and services including Facebook Pixel, EMC Avamar, Preact, and more. Explore Polpharma Biologics's tech stack below.

  • Facebook Pixel
    Analytics
  • EMC Avamar
    Backup And Recovery
  • Preact
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Zabbix
    Miscellaneous
  • Palo Alto Firewalls
    Network Hardware
  • VMware
    Virtualisation Software

Media & News

Polpharma Biologics's Email Address Formats

Polpharma Biologics uses at least 1 format(s):
Polpharma Biologics Email FormatsExamplePercentage
First.Last@polpharmabiologics.comJohn.Doe@polpharmabiologics.com
99%
First.M.Last@polpharmabiologics.comJohn.M.Doe@polpharmabiologics.com
1%

Frequently Asked Questions

Where is Polpharma Biologics's headquarters located?

Minus sign iconPlus sign icon
Polpharma Biologics's main headquarters is located at ulica Trzy Lipy 3 PL Gdańsk, Pomorskie 80-172 PL. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Polpharma Biologics's official website and social media links?

Minus sign iconPlus sign icon
Polpharma Biologics's official website is polpharmabiologics.com and has social profiles on LinkedIn.

How much revenue does Polpharma Biologics generate?

Minus sign iconPlus sign icon
As of October 2024, Polpharma Biologics's annual revenue reached $750M.

What is Polpharma Biologics's SIC code NAICS code?

Minus sign iconPlus sign icon
Polpharma Biologics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Polpharma Biologics have currently?

Minus sign iconPlus sign icon
As of October 2024, Polpharma Biologics has approximately 1.1K employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Technical Officer And Vice-President Of The Management Board @ Polpharma Biologics Sa: F. P.Chief Business Officer: H. T.Chief Quality Officer: M. B.. Explore Polpharma Biologics's employee directory with LeadIQ.

What industry does Polpharma Biologics belong to?

Minus sign iconPlus sign icon
Polpharma Biologics operates in the Biotechnology Research industry.

What technology does Polpharma Biologics use?

Minus sign iconPlus sign icon
Polpharma Biologics's tech stack includes Facebook PixelEMC AvamarPreactjQuery MigratejQueryZabbixPalo Alto FirewallsVMware.

What is Polpharma Biologics's email format?

Minus sign iconPlus sign icon
Polpharma Biologics's email format typically follows the pattern of . Find more Polpharma Biologics email formats with LeadIQ.
Polpharma Biologics

Polpharma Biologics

Biotechnology ResearchPomorskie, Poland1001-5000 Employees

Our mission is to create quality biologics with a passion to improve the lives of patients. 

Polpharma Biologics is an international biotechnology company with integrated operations in the European Union (EU), developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas. 
Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production preparing drugs for future commercial partnerships with global pharmaceutical players. The company’s expertise is in the development and manufacturing of medicines based on microbial and mammalian expression systems. 
With its cell line development center in Netherlands and two centers of development and manufacturing in Poland, Polpharma Biologics creates growth and development opportunities for biotechnology specialists.

Find out more at our website

Section iconCompany Overview

Headquarters
ulica Trzy Lipy 3 PL Gdańsk, Pomorskie 80-172 PL
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $100M$1B

    Polpharma Biologics's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Polpharma Biologics's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.